Advanced SearchSearch Tips
KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 48, Issue 10,  2015, pp.571-576
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2015.48.10.015
 Title & Authors
KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway
Song, In-Sung; Jeong, Yu Jeong; Nyamaa, Bayalagmaa; Jeong, Seung Hun; Kim, Hyoung Kyu; Kim, Nari; Ko, Kyung Soo; Rhee, Byoung Doo; Han, Jin;
  PDF(new window)
SB743921 is a potent inhibitor of the spindle protein kinesin and is being investigated in ongoing clinical trials for the treatment of myeloma. However, little is known about the molecular events underlying the induction of cell death in multiple myeloma (MM) by SB743921, alone or in combination treatment. Here, we report that SB743921 induces mitochondria-mediated cell death via inhibition of the signaling pathway, but does not cause cell cycle arrest in KMS20 MM cells. SB743921-mediated inhibition of the pathway results in reduced expression of SOD2 and Mcl-1, leading to mitochondrial dysfunction. We also found that combination treatment with SB743921 and bortezomib induces death in bortezomib-resistant KMS20 cells. Altogether, these data suggest that treatment with SB743921 alone or in combination with bortezomib offers excellent translational potential and promises to be a novel MM therapy.
SB743921;;multiple myeloma;combination therapy;superoxide dismutase 2;Mcl-1;
 Cited by
KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL, Anti-Cancer Drugs, 2016, 27, 9, 863  crossref(new windwow)
Kyle RA and Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351, 1860-1873 crossref(new window)

San Miguel J, Blade J, Boccadoro M et al (2006) A practical update on the use of bortezomib in the management of multiple myeloma. Oncologist 11, 51-61 crossref(new window)

Chauhan D, Li G, Podar K et al (2004) Targeting mitochondria to overcome conventional and bortezomib/ proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells. Blood 104, 2458-2466 crossref(new window)

Ocio EM, Mateos MV, Maiso P, Pandiella A and San- Miguel JF (2008) New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings. Lancet Oncol 9, 1157-1165 crossref(new window)

Hanahan D and Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70 crossref(new window)

Vale RD and Fletterick RJ (1997) The design plan of kinesin motors. Annu Rev Cell Dev Biol 13, 745-777 crossref(new window)

Enos AP and Morris NR (1990) Mutation of a gene that encodes a kinesin-like protein blocks nuclear division in A. nidulans. Cell 60, 1019-1027 crossref(new window)

Sawin KE and Mitchison TJ (1995) Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle. Proc Natl Acad Sci U S A 92, 4289-4293 crossref(new window)

Rowinsky EK, Chaudhry V, Cornblath DR and Donehower RC (1993) Neurotoxicity of Taxol. J Natl Cancer Inst Monogr, 107-115

Talapatra SK, Anthony NG, Mackay SP and Kozielski F (2013) Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism. J Med Chem 56, 6317-6329 crossref(new window)

Yin Y, Sun H, Xu J et al (2014) Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells. Leuk Lymphoma, 1-8

Tan G, Heqing L, Jiangbo C et al (2002) Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Int J Cancer 97, 168-172 crossref(new window)

Esteve MA, Carre M and Braguer D (2007) Microtubules in apoptosis induction: are they necessary? Curr Cancer Drug Targets 7, 713-729 crossref(new window)

Staudt LM (2010) Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol 2, a000109 crossref(new window)

DiDonato JA, Mercurio F and Karin M (2012) NF-kappaB and the link between inflammation and cancer. Immunol Rev 246, 379-400 crossref(new window)

Song IS, Kim HK, Lee SR et al (2013) Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells. Int J Cancer 133, 1357-1368 crossref(new window)

Park J, Bae EK, Lee C et al (2014) Establishment and characterization of bortezomib-resistant U266 cell line: constitutive activation of NF-kappaB-mediated cell signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis. BMB Rep 47, 274-279 crossref(new window)

Yi MJ, Park SH, Cho HN et al (2002) Heat-shock protein 25 (Hspb1) regulates manganese superoxide dismutase through activation of Nfkb (NF-kappaB). Radiat Res 158, 641-649 crossref(new window)

Lam LT, Davis RE, Pierce J et al (2005) Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 11, 28-40 crossref(new window)

Richardson PG, Hideshima T, Mitsiades C and Anderson KC (2007) The emerging role of novel therapies for the treatment of relapsed myeloma. J Natl Compr Canc Netw 5, 149-162

Lonial S, Waller EK, Richardson PG et al (2005) Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood 106, 3777-3784 crossref(new window)

Song IS, Jeong YJ, Jeong SH et al (2013) Combination treatment with 2-methoxyestradiol overcomes bortezomib resistance of multiple myeloma cells. Exp Mol Med 45, e50 crossref(new window)

Kong PJ, Byun JS, Lim SY et al (2008) Melatonin Induces Akt Phosphorylation through Melatonin Receptor- and PI3K-Dependent Pathways in Primary Astrocytes. Korean J Physiol Pharmacol 12, 37-41 crossref(new window)

Xie H, Hu J, Pan H, Lou Y, Lv P, Chen Y (2014) Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells. BMB Rep 47, 104-109 crossref(new window)

Liu SJ, Yin CX, Ding MC, Xia SY, Shen QM, Wu JD (2014) Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB. BMB Rep 47, 388-392 crossref(new window)